Glucosylceramide modulates membrane traffic along the endocytic pathway. - Wikidata - awgldk - TriplyDB

Glucosylceramide modulates membrane traffic along the endocytic pathway.

Glucosylceramide modulates membrane traffic along the endocytic pathway.

http://www.wikidata.org/entity/Q44195483

about

Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.Glycolipid trafficking in Drosophila undergoes pathway switching in response to aberrant cholesterol levels Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry.Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol.Common and uncommon pathogenic cascades in lysosomal storage diseases The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1.Adamantyl glycosphingolipids provide a new approach to the selective regulation of cellular glycosphingolipid metabolism.Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.The cell biology of lysosomal storage disorders.Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.Sterol carrier protein-2: new roles in regulating lipid rafts and signaling.Storage solutions: treating lysosomal disorders of the brain.Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy.Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants.Lipid composition of microdomains is altered in a cell model of Gaucher disease.Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.Use of Bodipy-labeled sphingolipid and cholesterol analogs to examine membrane microdomains in cells Autophagy, mitochondria and cell death in lysosomal storage diseases.Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease Glycosphingolipid functions Glucosylceramide Reorganizes Cholesterol-Containing Domains in a Fluid Phospholipid Membrane.Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts.The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin.Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator.Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis.Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.Mechanisms of Gaucher disease pathogenesis Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.

P2860

Q28267787-D45394E5-A66B-4A02-BEAA-336784FC7BAA Q28506553-8EC70B19-FE19-40B6-A44A-A9ACE2ED7190 Q28555118-FE450810-1487-4AFD-A905-D1202CDCEB15 Q28943547-21B258E3-9C63-4280-A03C-06AAC209744F Q30367337-16AE9ECD-E7B5-4CB9-A965-A9EAB6DB07BF Q30493377-49894850-5088-4BF8-8D31-C2EB170646E4 Q30496213-C6F68347-8665-41D7-924D-91720A5CEBB6 Q33440784-F925AE57-1E1F-4F1E-989B-00D517F04CA1 Q33897702-32EB3941-0673-4FBF-9E16-1E46BFD6AC3C Q33966917-C05BEC3C-628C-4A02-861D-72EE82C80F36 Q34407346-571A0B6F-53A3-4075-94BD-188A2061DE90 Q35056076-4D3CBD60-810D-40F7-865C-D0DB65409192 Q35065197-2408ACEB-1CB8-4659-899D-AE45C88E11BF Q35153223-872963E1-0B6C-4E2D-8752-80D6D467F701 Q35195374-CEAA1F42-86C0-4CA0-B699-F3530E286D85 Q35324757-280D437F-BEDD-409F-A343-E4CD8B7B8B85 Q35825859-55604AC6-71F3-4FBF-B3CE-2295292D0727 Q35956792-C7A97471-CD8B-41E4-8C8E-842DEA71E3C3 Q35982198-F09ED659-5AF2-4658-974C-C406C1509A28 Q36008041-9B260670-FED4-4E02-9E09-7F397A1280D1 Q36210235-DFC85CE7-DB74-4FD5-89C3-39178D584D03 Q36363960-F6083FA2-D049-479E-9FF3-3028B742DC42 Q36677618-75894D9C-2D3A-4810-BA0E-083A75EDAF8D Q36745037-3394E49A-459E-405F-9B5B-897F4563077A Q37189795-BB9F1C9E-A315-4F83-AE83-1D4A93FA35D3 Q37280712-237A70E6-BEAD-46D4-8A87-0A3DF5B87DED Q37421398-15DE4E3E-42A1-46A5-B0AE-DB7C493B5D40 Q37524224-B2B38CD5-8AC0-4C89-BECB-32A5DD7E1968 Q37528927-732AFB44-B154-4878-8DCB-9CE2AC21FAA0 Q37873655-E3D7387B-81F1-489D-BA9A-BFFB00F0838B Q38273069-7254DAFE-2989-4C5B-BD33-4D6CFDB04C87 Q39360277-03AEDCAD-F323-415B-B76A-2AF0A6F3E0EF Q39410832-80913D8B-F165-4731-B8C7-4A5A13F4D001 Q39421907-01E19F31-E5F6-4108-9C6F-E073FF8C2390 Q39849586-D6695543-F6B0-48B8-86BF-750ABC7EA752 Q40423407-145915A4-1B78-40BE-B1C2-D9395D88536F Q40609398-8106EB75-0876-411C-8638-DF43816C594C Q41811577-53F0F441-DE49-4446-9BFF-79CC4A954402 Q42059532-0BF8171C-8BF1-4126-A15B-CA8CFF5BC433 Q42172548-A8722EDB-BF3D-4294-A845-83483A3E2DD7

P2860

Glucosylceramide modulates membrane traffic along the endocytic pathway.

http://www.wikidata.org/entity/Q44195483

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Glucosylceramide modulates membrane traffic along the endocytic pathway.

@en

Glucosylceramide modulates membrane traffic along the endocytic pathway.

@nl

type

label

Glucosylceramide modulates membrane traffic along the endocytic pathway.

@en

Glucosylceramide modulates membrane traffic along the endocytic pathway.

@nl

prefLabel

Glucosylceramide modulates membrane traffic along the endocytic pathway.

@en

Glucosylceramide modulates membrane traffic along the endocytic pathway.

@nl

P1433

Q44195483-C3D62A19-055D-447B-B878-E7C83A3033EE

P1476

Q44195483-F4EA0904-6498-4C87-BD76-B4155B4F5C03

P2093

Q44195483-A9C3C109-5B8F-43B3-A3CD-1109FAE92090

Q44195483-AC84B687-A540-4B7C-88FC-9C326F806156

Q44195483-B0D966EF-2990-4C53-BB84-6E3E2C4B6CC9

Q44195483-B64DE7D1-B1AE-4F71-9D20-01C186A02682

Q44195483-F594DE14-B7AF-4F8A-9D89-48CD31D25C5C

P2860

Q44195483-0527577C-9734-4FE1-BA60-CA7A55EC1B04

Q44195483-08C13DEA-472A-4AD5-819F-2A652F5A8B32

Q44195483-2E05A7E3-44F6-4FBF-AAC5-ACC1D9EED5ED

Q44195483-376AEE3E-7C8B-4DF5-9215-B43CE7FFFE81

Q44195483-3824362A-3FA0-412C-A4DF-842BA43A71EE

Q44195483-3BFDD57D-DA4C-4AB2-AFAB-29CCC8849F88

Q44195483-3CEF8BAF-8CCC-408E-96A3-9DB934EC552B

Q44195483-45D34DAA-0F4A-427A-AEC3-975D084CDBD1

Q44195483-8358CB52-B6A8-4C73-8065-A8321B981CFE

Q44195483-89C2DB1A-C68F-423B-87BC-C8F8B65A9353

P304

Q44195483-503F8595-C921-4CCB-999C-4DCC6351B122

P31

Q44195483-B8645B71-EEE7-45CF-B55D-EADFB282E7B5

P356

Q44195483-821A0395-BA7A-49B0-AE66-1D57D81A6631

P433

Q44195483-F7CBD9ED-1F9C-4BCF-9459-9D6A9DF41289

P478

Q44195483-B8C867F5-C397-4A19-9481-90F3A42E8F87

P50

Q44195483-28076FE4-F206-4746-A820-772B30CE9D3F

Q44195483-394D80D4-D939-4818-BB06-1460BCC92389

P577

Q44195483-B4BCE903-7BA6-4F4A-94B4-AAFBA5E15F17

P698

Q44195483-B008B59A-D6A8-4A67-AAE2-A6D9EB3EB709

P356

JLR.M200232-JLR200

P1433

Journal of Lipid Research

P1476

Glucosylceramide modulates membrane traffic along the endocytic pathway.

@en

P2093

Dan J Sillence

http://www.w3.org/2001/XMLSchema#string

David L Marks

http://www.w3.org/2001/XMLSchema#string

Raymond A Dwek

http://www.w3.org/2001/XMLSchema#string

Richard E Pagano

http://www.w3.org/2001/XMLSchema#string

Terry D Butters

http://www.w3.org/2001/XMLSchema#string

P2860

Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease

Identification of a molecular target of psychosine and its role in globoid cell formation.

Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells

Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface

Sterol-modulated glycolipid sorting occurs in niemann-pick C1 late endosomes.

Substrate reduction therapy for glycosphingolipid storage disorders.

The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo.

Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.

Membrane traffic in sphingolipid storage diseases.

Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway.

P304

1837-1845

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M200232-JLR200

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Vishwajeet Puri

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12401882

http://www.w3.org/2001/XMLSchema#string